The reducing end of heparan sulfate has been known for a long time, but information on the non-reducing end has been lacking. Recent studies indicate that the non-reducing end of heparan sulfate might be the place where fibroblast growth factor signaling complex forms. The non-reducing end also changes with heparanase digestion and, thus, might serve as a marker for tumor pathology. Using high performance liquid chromatography-coupled mass spectrometry, we have identified and characterized the non-reducing end of bovine kidney heparan sulfate. We find that the non-reducing end region is highly sulfated and starts with a glucuronic acid (GlcA) residue. The likely sequence of the non-reducing end hexasaccharides is GlcA-GlcNS6S-UA ± 2S-GlcNS ± 6S-Ido2S-GlcNS ± 6S (where GlcNS is N-sulfate-D-glucosamine, S is sulfate, UA is uronic acid, and Ido is iduronic acid). Our data suggests that the non-reducing end of bovine kidney heparan sulfate is not trimmed by heparanase and is capable of supporting fibroblast growth factor signaling complex formation. © 2005 by The American Society for Biochemistry and Molecular Biology, Inc.
CITATION STYLE
Wu, Z. L., & Lech, M. (2005). Characterizing the non-reducing end structure of heparan sulfate. Journal of Biological Chemistry, 280(40), 33749–33755. https://doi.org/10.1074/jbc.M505677200
Mendeley helps you to discover research relevant for your work.